Cytokines and anti-cytokine biologicals in autoimmunity: present and future
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 13 (4-5) , 299-313
- https://doi.org/10.1016/s1359-6101(02)00018-7
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- TWIN CONCORDANCE RATES FOR RHEUMATOID ARTHRITIS: RESULTS FROM A NATIONWIDE STUDYRheumatology, 1993
- LOCALIZATION OF INTERLEUKIN-1α, TYPE 1 INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE SYNOVIAL MEMBRANE AND CARTILAGE/PANNUS JUNCTION IN RHEUMATOID ARTHRITISRheumatology, 1992
- In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritisClinical Immunology and Immunopathology, 1992